The Express Tribune (blog) |
My visit to Aga Khan Hospital’s cancer ward
The Express Tribune (blog) Rituximab (rituxan) helps the immune system to attack the cancer cells and Avastin is a monoclonal antibody that can treat a number of cancers except breast cancer. It intercepts the tumour signals and stops them from connecting their targets. Many … |
UT MD Anderson Cancer Moon Shots Take Flight During Year 1HispanicBusiness.comChronic Lymphocytic Leukemia Moon Shot will soon open a 200-patient clinical trial to test the promising experimental drug ibrutinib with or without the existing antibody rit…
|
Cimzia® (Certolizumab Pegol) Approved by FDA for Treatment of Adults with …
Sacramento Bee Formal drug interaction studies have not been performed with rituximab or natalizumab; however, because of the nature of the adverse events seen with these combinations with TNF blocker therapy, similar toxicities may also result from the use of CIMZIA … |
|
Cimzia® (Certolizumab Pegol) Approved by FDA for Treatment of Adults with …
PR Newswire (press release) Formal drug interaction studies have not been performed with rituximab or natalizumab; however, because of the nature of the adverse events seen with these combinations with TNF blocker therapy, similar toxicities may also result from the use of CIMZIA … |
|
Rituximab offered little therapeutic benefit in Graves’ ophthalmopathy
Healio SAN JUAN, Puerto Rico — In a randomized, double blind, placebo-controlled trial, rituximab did not effect significant clinical improvement in Graves’ ophthalmopathy and had a 50% success/failure rate in patients with the disease. “In patients with … |
|
Rituximab No Help in Graves’ Eye Disease
MedPage Today Ronald Koenig, MD, PhD, of the University of Michigan in Ann Arbor, who was not involved in the study, said that although the result is “disappointing, it is a very important finding since there is so much need for an effective therapy, and rituximab … Rituximab offered little therapeutic benefit in Graves’ ophthalmopathyHealio |
Wooed by State Spending, Russian Drugmaker Bets on BrazilThe Moscow TimesThe Biocad facility will produce the cancer-fighting trastuzumab, as well as pegylated interferon against rheumatoid arthritis, and rituximab to combat hepatitis type C. Last year…
|
Roche cancer drugs drive healthy sales rise
PharmaTimes The top-selling drug was MabThera/Rituxan (rituximab), approved for non-Hodgkin’s lymphoma and chronic lymphocytic leukaemia as well as rheumatoid arthritis, contributed 1.80 billion francs in the oncology setting, an increase of 12%. Sales of … |
|
David Schenkein, Cancer Doc Turned CEO, Aims to Build New Genentech
Xconomy He was recruited later to oversee the clinical development and regulatory work for several of South San Francisco, CA-based Genentech’s big cancer therapies like bevacizumab (Avastin), trastuzumab (Herceptin), and rituximab (Rituxan). Then, in May 2009 … |
Rituximab plus epratuzumab effective in follicular lymphomaHealioThe combination of rituximab and epratuzumab was associated with comparable response rates and time to progression as rituximab plus chemotherapy in a cohort of patients with previously u…